Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2022-03-01 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-014409 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | 2022-03-01 | SRPT | Rodino-Klapac Louise | CSO, Head of R, D | F - Tax | $75.05 | -572 | 65.3K | -0.9% | -$42.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | F | D | 572 | $75.05 | 65,327 | D | — | — | (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. (F2) The amount of securities directly owned by the reporting person includes 221 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on February 28, 2022. |